Efficacy and safety of anti-TNF therapy for inflammatory bowel disease (IBD) in liver transplant recipients for primary sclerosing cholangitis (PSC): a multicenter experience.

被引：0
|
作者：
Combes, R. [1 ]
Altwegg, R. [1 ]
Laharie, D. [2 ]
De Ledinghen, V. [2 ]
Radenne, S. [3 ]
Conti, F. [4 ]
Chazouilleres, O. [4 ]
Duvoux, C. [5 ]
Peyrin-Biroulet, L. [6 ]
Dumortier, J. [7 ]
Leroy, V. [8 ]
Treton, X. [9 ]
Durand, F. [9 ]
Dharancy, S. [10 ]
Nachury, M. [10 ]
Goutorbe, F. [11 ]
Lamblin, G. [11 ]
Pageaux, G. -P. [1 ]
机构：
[1] Univ Hosp St Eloi, Dept Hepatol & Gastroenterol, Montpellier, France
[2] Univ Hosp Bordeaux, Haut Leveque Hosp, Hepatogastroenterol, Bordeaux, France
[3] Hosp Civils Lyon, Croix Rousse, Hepatogastroenterol, Lyon, France
[4] Univ Hosp St Antoine, APHP, Hepatogastroenterol, Paris, France
[5] Univ Hosp Henri Mondor, APHP, Hepatogastroenterol, Creteil, France
[6] Univ Hosp Nancy, Gastroenterol, Nancy, France
[7] Hosp Civils Lyon, Edouard Heriot Hosp, Hepatogastroenterol, Lyon, France
[8] Univ Hosp Grenoble, Hepatogastroenterol, Grenoble, France
[9] Univ Hosp Beaujon, APHP, Gastroenterol, Clichy, France
[10] Univ Hosp Lille, Hepatogastroenterol, Lille, France
[11] Univ Hosp Clermont Ferrand, Hepatogastroenterol, Clermont Ferrand, France
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP033
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [31] The Types of Inflammatory Bowel Disease (IBD) Predispose to Distinct Clinical Phenotypes of Primary Sclerosing Cholangitis (PSC) in Children
    Jones, Keaton R.
    Bufler, Philip
    Miethke, Alexander G.
    GASTROENTEROLOGY, 2014, 146 (05) : S928 - S929
  • [32] PREVALENCE OF PRIMARY SCLEROSING CHOLANGITIS (PSC) IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE (IBD) - A PROSPECTIVE-STUDY
    PODESTA, A
    SAMBUELLI, A
    GIL, A
    MIGUEZ, C
    GONCALVEZ, S
    NEGREIRA, S
    KOGAN, Z
    BOERR, L
    TERG, R
    HEPATOLOGY, 1995, 22 (04) : 1480 - 1480
  • [33] The Impact of Biological Therapy on Liver Transplant Outcomes in Pvvvatients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Kochhar, Gursimran
    Kim, Ahyoung
    Jegadeesan, Ramprasad
    Fialho, Andrea
    Fialho, Andre
    Shen, Bo
    Romero-marrero, Carlos
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S844 - S844
  • [34] Survival Outcomes of Liver Transplant Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Mousa, Omar Y.
    Patel, Neej J.
    Pang, Maoyin
    Nimri, Sarah M.
    Harnois, Denise
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S511 - S512
  • [35] Primary sclerosing cholangitis and chronic inflammatory bowel disease: post liver transplant evolution
    Flattet, Yves
    Frossard, Jean-Louis
    Spahr, Laurent
    Moradpour, Darius
    Fraga, Montserrat
    Compagnon, Philippe
    Magini, Giulia
    Goossens, Nicolas
    SWISS MEDICAL WEEKLY, 2021, 151 : 25 - 25
  • [36] EFFICACY OF VEDOLIZUMAB IN REDUCING BILIARY INFLAMMATION IN PRIMARY SCLEROSING CHOLANGITIS (PSC) IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
    Tse, Chung Sang
    Loftus, Edward V.
    Raffals, Laura H.
    Gossard, Andrea
    Lightner, Amy L.
    GASTROENTEROLOGY, 2017, 152 (05) : S402 - S403
  • [37] Inflammatory Bowel Disease Activity in Patients Undergoing Liver Transplant for Primary Sclerosing Cholangitis
    Parekh, Ravish
    Segovia, Cristina
    Kaur, Nirmal
    GASTROENTEROLOGY, 2016, 150 (04) : S407 - S408
  • [38] Colonoscopic Surveillance in Inflammatory Bowel Disease Post Liver Transplant for Primary Sclerosing Cholangitis
    Pavendranathan, Gokulan
    Selby, Warwick
    Shackel, Nicholas A.
    Strasser, Simone I.
    McCaughan, Geoffrey W.
    Koorey, David J.
    GASTROENTEROLOGY, 2009, 136 (05) : A814 - A814
  • [39] Colonoscopic surveillance in inflammatory bowel disease post liver transplant for primary sclerosing cholangitis
    Pavendranathan, G.
    Selby, W. S.
    Shackel, N. A.
    Strasser, S. I.
    Mccaughan, G. W.
    Koorey, D. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A272 - A272
  • [40] Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals With Inflammatory Bowel Disease
    Eksteen, Bertus
    Heatherington, Joan
    Oshiomogho, John I.
    Panaccione, Remo
    Kaplan, Gilaad
    Ghosh, Subrata
    GASTROENTEROLOGY, 2016, 150 (04) : S1268 - S1268
12345